World's first international patient receives solid tumour CAR-T therapy Satri-cel in Shanghai
July 07, 2026 | 15:23
Jiahui International Cancer Center in Shanghai treated the world's first international patient with Satri-cel, the first approved CAR-T therapy for solid tumours, marking a milestone in extending access to China's frontier oncology treatments.
CARsgen showcases Satri-cel breakthroughs at ASCO 2025 and in The Lancet
June 02, 2025 | 16:29
Dual milestone affirms Satri-cel’s potential in solid tumour immunotherapy and advances CAR-T research.
CARsgen's Satri-cel Immunotherapy Makes ASCO Debut
May 23, 2025 | 08:00
The CAR-T cell therapy candidate garners attention for its potential in solid tumor treatment.
Mobile Version